Lamar Health (formerly MoGen)

Flatiron for Rare DiseaseRare disease treatment has a lot of trial and error due to small numbers of patients. MoGen is solving this by building a database of genetic-treatment-outcome information. Data is collected and aggregated from our clinician & patient portal designed to manage complicated conditions. We have developed a proprietary AI model to help tailor search results based on genotype. We plan on expanding from this target space into additional rare genetic disease and contribute to efforts in diagnostics and therapeutics using the data we collect. Our founding team is stacked with Stanford alumni with PhDs in Genetics, founders with profitable startups and a family member of a rare disease patient. Here’s a link to my Calendly if you'd like to reach us: https://calendly.com/mogenceo/30min

ACTIVE FOUNDERS

Founder 1

Eesha Sharma,

I am co-Founder of an early stage biotech start-up, MoGen. Our company is developing a search engine for rare metabolic disease treatment. These conditions lead to developmental disability if not treated properly. I've been on the patient-family side of this problem. After getting my PhD in Molecular Genetics I thought it was about time to flip the table and do something about it.

Twitter: | Linkedin: https://linkedin.com/in/eesha-sharma-50a99119a

Founder 2

,

Twitter: | Linkedin:

Founder 3

,

Twitter: | Linkedin:

Founder 4

,

Twitter: | Linkedin:

Founder 5

,

Twitter: | Linkedin:

Founder 6

,

Twitter: | Linkedin: